H10: additional manufacturer narrative: the device was not returned for evaluation, as the device request is ongoing.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
Added information to section h6 (device code(s)), h6 (investigation findings) and h6 (investigations conclusions).Corrected data h6 (device code(s)): "1261 - material fragmentation" code removed.The serial number was not provided.Therefore, the device history record (dhr) could not be reviewed.The device was not returned for evaluation, therefore customer report of leaflet damaged could not be confirmed by product evaluation.Devices are typically explanted or treated because they are not functioning optimally.In some cases, the failure mode is unknown.Other times, it may be reported as stenosis, increased/high gradient, regurgitation, thickened leaflet; leaflet tear, immobility, restriction, or difficulty coapting.These may be a manifestation of structural valve deterioration (svd) or nonstructural dysfunction (nsvd).Tissue degeneration-related structural deterioration, either calcific or non-calcific, are common chronic failure modes for this type of bioprosthetic heart valve.Operational mechanical stress and biological factors are generally believed to be the major contributors to the non-calcific bioprosthetic tissue degeneration.Degeneration-related structural deterioration is most commonly related to patient factors and is not usually an indication of a device malfunction related to a manufacturing deficiency.Nonstructural valve dysfunction (nsvd) is any abnormality not intrinsic to the valve itself that results in dysfunction of the prosthetic valve.The term nsvd refers to problems that do not directly involve valve components yet results in dysfunction of the prosthetic valve; such problems can include entrapment by pannus, tissue, or suture, malposition, patient prosthesis mismatch, thrombosis, or technical errors.The instructions for use (ifu) have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.The reported type of event is included in the ifu.Pa definitive root cause cannot be conclusively determined; however, patient factors likely caused or contributed.
|